{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T20:39:01Z","timestamp":1758055141079,"version":"3.44.0"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,15]]},"DOI":"10.7759\/cureus.92333","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T07:05:06Z","timestamp":1757919906000},"source":"Crossref","is-referenced-by-count":0,"title":["Atypical Parathyroid Tumor and Hyperparathyroidism, and Their Association With the CDC73 Mutation in a Pediatric Patient"],"prefix":"10.7759","author":[{"given":"Veronica D","family":"Gullapalli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jarreau","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1515\/jpem-2022-0299","article-title":"Heterozygous CDC73 mutation causing hyperparathyroidism in children and adolescents: a report of 2 cases","volume":"35","author":"Blackburn J","year":"2022","unstructured":"Blackburn J, Mulvey I, Nadar R, Dias RP, Saraff V, Senniappan S. Heterozygous CDC73 mutation causing hyperparathyroidism in children and adolescents: a report of 2 cases. J Pediatr Endocrinol Metab. 2022, 35:1547-51. 10.1515\/jpem-2022-0299","journal-title":"J Pediatr Endocrinol Metab"},{"key":"ref2","article-title":"CDC73-related disorders","author":"Skefos CM","year":"2008","unstructured":"Skefos CM, Waguespack SG, Perrier ND, Hu MI. CDC73-related disorders. GeneReviews\u00ae [Internet]. Adam MP, Feldman J, Mirzaa GM, et al. (ed): University of Washington, Seattle; 2008."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2017-01249","article-title":"CDC73-related disorders: clinical manifestations and case detection in primary hyperparathyroidism","volume":"102","author":"van der Tuin K","year":"2017","unstructured":"van der Tuin K, Tops CM, Adank MA, et al.. CDC73-related disorders: clinical manifestations and case detection in primary hyperparathyroidism. J Clin Endocrinol Metab. 2017, 102:4534-40. 10.1210\/jc.2017-01249","journal-title":"J Clin Endocrinol Metab"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-19-0135","article-title":"Atypical parathyroid adenomas: challenging lesions in the differential diagnosis of endocrine tumors","volume":"26","author":"Cetani F","year":"2019","unstructured":"Cetani F, Marcocci C, Torregrossa L, Pardi E. Atypical parathyroid adenomas: challenging lesions in the differential diagnosis of endocrine tumors. Endocr Relat Cancer. 2019, 26:R441-64. 10.1530\/ERC-19-0135","journal-title":"Endocr Relat Cancer"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1158474","article-title":"Recurrence and mortality rate in an Italian multi-center case series of parathyroid atypical adenomas and carcinomas","volume":"14","author":"Barale M","year":"2023","unstructured":"Barale M, Nervo A, Craparo A, et al.. Recurrence and mortality rate in an Italian multi-center case series of parathyroid atypical adenomas and carcinomas. Front Endocrinol (Lausanne). 2023, 14:1158474. 10.3389\/fendo.2023.1158474","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvae163.2271","article-title":"7508 primary hyperparathyroidism caused by a CDC73-related atypical parathyroid tumor","volume":"8","author":"Cardenas R","year":"2024","unstructured":"Cardenas R, Tariq S, Habibi R, Ebrahimi N, Astiazaran-Symonds E. 7508 primary hyperparathyroidism caused by a CDC73-related atypical parathyroid tumor. J Endocr Soc. 2024, 8:bvae163.2271. 10.1210\/jendso\/bvae163.2271","journal-title":"J Endocr Soc"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1413","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop","volume":"99","author":"Bilezikian JP","year":"2014","unstructured":"Bilezikian JP, Brandi ML, Eastell R, Silverberg SJ, Udelsman R, Marcocci C, Potts JT Jr. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab. 2014, 99:3561-9. 10.1210\/jc.2014-1413","journal-title":"J Clin Endocrinol Metab"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1027598","article-title":"Clinical and genetic analysis of atypical parathyroid adenoma compared with parathyroid carcinoma and benign lesions in a Chinese cohort","volume":"14","author":"Chen Y","year":"2023","unstructured":"Chen Y, Song A, Nie M, et al.. Clinical and genetic analysis of atypical parathyroid adenoma compared with parathyroid carcinoma and benign lesions in a Chinese cohort. Front Endocrinol (Lausanne). 2023, 14:1027598. 10.3389\/fendo.2023.1027598","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/384195-atypical-parathyroid-tumor-and-hyperparathyroidism-and-their-association-with-the-cdc73-mutation-in-a-pediatric-patient","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T07:05:07Z","timestamp":1757919907000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/384195-atypical-parathyroid-tumor-and-hyperparathyroidism-and-their-association-with-the-cdc73-mutation-in-a-pediatric-patient"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,15]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.92333","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,15]]}}}